5% OFF
5% OFF
Otrivin Paediatric 0.05% w/v Nasal Drops is a highly potent synthetic local vasoconstrictor formulation containing Xylometazoline Hydrochloride (0.05% w/v), engineered under strict clinical standards to control severe upper respiratory nasal... Read more
Otrivin Paediatric 0.05% w/v Nasal Drops is a highly potent synthetic local vasoconstrictor formulation containing Xylometazoline Hydrochloride (0.05% w/v), engineered under strict clinical standards to control severe upper respiratory nasal tracking errors. It acts by stimulating alpha-adrenergic receptors on the smooth muscles of the nasal mucosa to accurately constrict dilated blood vessels, offering a decisive clinical path to regulate chronic respiratory airflow. By limiting fluid retention, localized mucosal edema, and rapid tissue hyper-shedding inside the nasal and paranasal pathways, it deeply alleviates persistent breathing blockages and intense local fluid accumulation. It directly acts on specific vascular receptors within the nasal cavity and respiratory pathways, serving as a reliable intervention for local decongestion and temporary airway clearance under direct medical guidance. Read less
Comprehensive information about the product
Otrivin Paediatric 0.05% w/v Nasal Drops is a highly potent synthetic local vasoconstrictor formulation containing Xylometazoline Hydrochloride (0.05% w/v), engineered under strict clinical standards to control severe upper respiratory nasal tracking errors. It acts by stimulating alpha-adrenergic receptors on the smooth muscles of the nasal mucosa to accurately constrict dilated blood vessels, offering a decisive clinical path to regulate chronic respiratory airflow. By limiting fluid retention, localized mucosal edema, and rapid tissue hyper-shedding inside the nasal and paranasal pathways, it deeply alleviates persistent breathing blockages and intense local fluid accumulation. It directly acts on specific vascular receptors within the nasal cavity and respiratory pathways, serving as a reliable intervention for local decongestion and temporary airway clearance under direct medical guidance.
Detailed product specifications and details
Otrivin Paediatric
Xylometazoline (0.05% w/v)
GlaxoSmithKline Consumer Healthcare
Respiratory Care
10 ml
Bottle
No
store below 30 degree
Feb 2026
Proper usage instructions for best results
Understanding the mechanism of action
Possible side effects and reactions
When using Otrivin Paediatric 0.05% w/v Nasal Drops, understanding its potential side effects and safety profile helps ensure a safe and effective recovery. While this medication is generally well-tolerated when used as directed, being aware of potential bodily responses ensures you can manage your treatment safely.
Local Nasal System: Transient burning, stinging, dryness inside the nose, and mild sneezing immediately after application.
Nervous System: Mild irritability, restlessness, or temporary sleep disturbances in sensitive young children.
Cardiovascular System: Mild palpitations or a transient increase in blood pressure due to local vasoconstriction absorption.
Severe Allergic Reactions: Widespread skin rash, hives, severe itching, or sudden swelling of the face, lips, tongue, or throat.
Serious Adverse Reactions: Severe burning or irritation inside the nose, persistent rapid heartbeat, excessive drowsiness, dizziness, or worsening nasal congestion (rhinitis medicamentosa) due to prolonged use.
Pre-existing Conditions: Consult your pediatrician before use if the child has a history of high blood pressure, heart disease, diabetes, thyroid disorders, or congenital health conditions.
Age & Usage Restrictions: Strictly adhere to the age-appropriate formulation (specifically designated for pediatric use) and do not use continuously for more than 3 to 5 days to avoid rebound congestion.
Usage Directions: Administer the exact dosage prescribed by your doctor, clean the dropper tip carefully after each use without contaminating it, and do not share the bottle with others to prevent the spread of infection.
Important precautions and warnings
Because this product is formulated for children and involves the delicate nasal passages, strict adherence to safety guidelines is essential:
Age Limit: This paediatric formulation is generally recommended for children under a certain age threshold (typically infants and children up to a specific age, as specified on the packaging). Always verify the correct age bracket and never use adult nasal drops on young children.
Duration of Use: Do not use these nasal drops continuously for more than 3 to 5 days. Prolonged use can lead to rebound congestion (rhinitis medicamentosa), where the nasal passages become even more congested once the medication wears off.
Dosage and Frequency: Strictly adhere to the recommended dosage and frequency prescribed by a pediatrician or indicated on the product label. Do not exceed the prescribed number of drops or applications per day.
Prevent Contamination: Do not let the tip of the dropper touch the inside of the nose, fingers, or any other surface to avoid transferring bacteria and contaminating the solution.
Medical Consultation: Consult a pediatrician before use if the child has pre-existing medical conditions such as high blood pressure, heart problems, diabetes, or a thyroid disorder.
Proper Administration Technique: Ensure the child is in a comfortable position (often lying down with the head tilted slightly backward) when administering the drops to prevent choking or discomfort.
Recommended dosage and administration
Common questions about this product